Literature DB >> 22146569

Endoplasmic reticulum stress is activated in endometrial adenocarcinoma.

Giuseppe Bifulco1, Claudia Miele, Bruno Di Jeso, Francesco Beguinot, Carmine Nappi, Costantino Di Carlo, Silvana Capuozzo, Giuseppe Terrazzano, Luigi Insabato, Luca Ulianich.   

Abstract

OBJECTIVES: Endometrial cancer is the most common malignancy of the female genital tract. However, in spite of a huge advance in our understanding of endometrial cancer biology, therapeutic modalities haven't significantly changed over the past 40 years. The activation of the Unfolded Protein Response (UPR) and GRP78 increase following Endoplasmic Reticulum (ER) stress have been recently identified as mechanisms favoring growth, invasion and resistance to therapy of different types of cancer. However, a possible role of ER stress and GRP78 in endometrial cancer has never been investigated.
METHODS: Tissue specimens from normal and neoplastic endometrium were analyzed for the expression of the ER stress markers GRP78, ATF6 and CHOP by Real-Time RT-PCR. In addition, GRP78 protein expression and localization were evaluated by Western blot and immunohistochemistry, respectively. The effect of GRP78 knock down on cell growth of Ishikawa cells was analyzed by proliferation curve analysis.
RESULTS: In this analysis, the expression levels of GRP78, ATF6 and CHOP mRNAs were significantly increased in specimens of endometrioid endometrial carcinomas. GRP78 and ATF6 protein expression levels were also increased in specimens of endometrial adenocarcinomas. GRP78 knock down caused a decrease of Ishikawa cells' growth.
CONCLUSIONS: The increased expression of ER stress markers in endometrioid endometrial carcinomas suggests a role for ER stress, the UPR and, possibly, GRP78 in endometrial cancer. Whether these mechanisms have a substantial function in the pathogenesis of malignant transformation of human endometrium is still under investigation in our laboratory. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22146569     DOI: 10.1016/j.ygyno.2011.11.045

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  21 in total

1.  Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response.

Authors:  Katherine E Tierney; Lingyun Ji; Shannon S Dralla; Eunjeong Yoo; Annie Yessaian; Huyen Q Pham; Lynda Roman; Richard Sposto; Paulette Mhawech-Fauceglia; Yvonne G Lin
Journal:  Gynecol Oncol       Date:  2016-10-19       Impact factor: 5.482

2.  Glucose-regulated protein 78 (GRP78) regulates colon cancer metastasis through EMT biomarkers and the NRF-2/HO-1 pathway.

Authors:  Yu-Jia Chang; Wei-Yu Chen; Chien-Yu Huang; Hui-Hsiung Liu; Po-Li Wei
Journal:  Tumour Biol       Date:  2014-11-28

3.  RNAi Screening of the Glucose-Regulated Chaperones in Cancer with Self-Assembled siRNA Nanostructures.

Authors:  Mayurbhai R Patel; Stephen D Kozuch; Christopher N Cultrara; Reeta Yadav; Suiying Huang; Uri Samuni; John Koren; Gabriela Chiosis; David Sabatino
Journal:  Nano Lett       Date:  2016-10-03       Impact factor: 11.189

4.  The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival.

Authors:  Koji Matsuo; Michael J Gray; Dong Yun Yang; Sucheta A Srivastava; Prem B Tripathi; Laura A Sonoda; Eun-Jeong Yoo; Louis Dubeau; Amy S Lee; Yvonne G Lin
Journal:  Gynecol Oncol       Date:  2012-11-28       Impact factor: 5.482

5.  Unfolded protein response, a link between endometrioid ovarian carcinoma and endometriosis: A pilot study.

Authors:  Andrea Ciavattini; Giovanni Delli Carpini; Matteo Serri; Alessandra Tozzi; Francesca Leoni; Eugenia Di Loreto; Franca Saccucci
Journal:  Oncol Lett       Date:  2018-08-02       Impact factor: 2.967

6.  Posttranscriptional regulation of PER1 underlies the oncogenic function of IREα.

Authors:  Olivier Pluquet; Nicolas Dejeans; Marion Bouchecareilh; Stephanie Lhomond; Raphael Pineau; Arisa Higa; Maylis Delugin; Chantal Combe; Sandrine Loriot; Gaelle Cubel; Nathalie Dugot-Senant; Anne Vital; Hugues Loiseau; Sara J C Gosline; Said Taouji; Michael Hallett; Jann N Sarkaria; Keith Anderson; Wenting Wu; Fausto J Rodriguez; Jean Rosenbaum; Frédéric Saltel; Martin E Fernandez-Zapico; Eric Chevet
Journal:  Cancer Res       Date:  2013-06-10       Impact factor: 12.701

7.  GRP78 expression and regulation in the mouse uterus during embryo implantation.

Authors:  PengFei Lin; YaPing Jin; XiangLi Lan; YanZhou Yang; Fenglei Chen; Nan Wang; Xiao Li; YuJie Sun; AiHua Wang
Journal:  J Mol Histol       Date:  2013-11-16       Impact factor: 2.611

8.  Interplay between unfolded protein response and autophagy promotes tumor drug resistance.

Authors:  Ming-Ming Yan; Jiang-Dong Ni; Deye Song; Muliang Ding; Jun Huang
Journal:  Oncol Lett       Date:  2015-07-17       Impact factor: 2.967

9.  Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer.

Authors:  Vishal Chandra; Rajani Rai; Doris Mangiaracina Benbrook
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

10.  A peptidic unconjugated GRP78/BiP ligand modulates the unfolded protein response and induces prostate cancer cell death.

Authors:  Danilo Maddalo; Antje Neeb; Katja Jehle; Katja Schmitz; Claudia Muhle-Goll; Liubov Shatkina; Tamara Vanessa Walther; Anja Bruchmann; Srinivasa M Gopal; Wolfgang Wenzel; Anne S Ulrich; Andrew C B Cato
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.